D-1438-2019 Class III Terminated
FDA drug recall D-1438-2019 was initiated by Amneal Pharmaceuticals, Inc. on Sep 25, 2017 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets. The recall status is terminated (terminated Aug 8, 2019). Affected quantity: 19104 units.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 10, 2019
- Initiation Date
- Sep 25, 2017
- Termination Date
- Aug 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 19104 units
Product description
Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottles, Rx Only, Manufactured by: Ammeal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Seton Pharmaceuticals Manasquan, NJ 08736, NDC 13925-171-01
Reason for recall
Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.
Distribution pattern
Nationwide within the United States
Code information
Lot #: HL05715, HL05815, Exp. 11/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1438-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026